JP2022526646A5 - - Google Patents
Info
- Publication number
- JP2022526646A5 JP2022526646A5 JP2021559793A JP2021559793A JP2022526646A5 JP 2022526646 A5 JP2022526646 A5 JP 2022526646A5 JP 2021559793 A JP2021559793 A JP 2021559793A JP 2021559793 A JP2021559793 A JP 2021559793A JP 2022526646 A5 JP2022526646 A5 JP 2022526646A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cell line
- nucleotide sequence
- expression
- sirna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024094278A JP7706607B2 (ja) | 2019-04-12 | 2024-06-11 | 操作された産生細胞株ならびにそれを作製および使用する方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962833548P | 2019-04-12 | 2019-04-12 | |
| US62/833,548 | 2019-04-12 | ||
| US201962839207P | 2019-04-26 | 2019-04-26 | |
| US62/839,207 | 2019-04-26 | ||
| US202062979483P | 2020-02-21 | 2020-02-21 | |
| US62/979,483 | 2020-02-21 | ||
| PCT/US2020/027489 WO2020210507A1 (en) | 2019-04-12 | 2020-04-09 | Engineered producer cell lines and methods of making and using the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024094278A Division JP7706607B2 (ja) | 2019-04-12 | 2024-06-11 | 操作された産生細胞株ならびにそれを作製および使用する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022526646A JP2022526646A (ja) | 2022-05-25 |
| JP2022526646A5 true JP2022526646A5 (https=) | 2023-04-17 |
| JP7560475B2 JP7560475B2 (ja) | 2024-10-02 |
Family
ID=70465550
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559793A Active JP7560475B2 (ja) | 2019-04-12 | 2020-04-09 | 操作された産生細胞株ならびにそれを作製および使用する方法 |
| JP2024094278A Active JP7706607B2 (ja) | 2019-04-12 | 2024-06-11 | 操作された産生細胞株ならびにそれを作製および使用する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024094278A Active JP7706607B2 (ja) | 2019-04-12 | 2024-06-11 | 操作された産生細胞株ならびにそれを作製および使用する方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US12018288B2 (https=) |
| EP (2) | EP4603579A3 (https=) |
| JP (2) | JP7560475B2 (https=) |
| KR (1) | KR20210152514A (https=) |
| CN (1) | CN113966395B (https=) |
| AU (1) | AU2020270960B2 (https=) |
| BR (1) | BR112021020391A2 (https=) |
| CA (1) | CA3136246A1 (https=) |
| CO (1) | CO2021013699A2 (https=) |
| IL (1) | IL287106A (https=) |
| MX (1) | MX2021012489A (https=) |
| PH (1) | PH12021552577A1 (https=) |
| SG (1) | SG11202110904PA (https=) |
| TW (1) | TWI859216B (https=) |
| WO (1) | WO2020210507A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023172491A1 (en) | 2022-03-07 | 2023-09-14 | Ultragenyx Pharmaceutical Inc. | Modified batch aav production systems and methods |
| US12054738B2 (en) | 2020-07-30 | 2024-08-06 | Shape Therapeutics Inc. | Stable cell lines for inducible production of rAAV virions |
| US20250019721A1 (en) | 2021-08-11 | 2025-01-16 | Ultragenyx Pharmaceutical Inc. | Compositions and methods for treating a muscular dystrophy |
| TW202323529A (zh) | 2021-10-18 | 2023-06-16 | 美商再生元醫藥公司 | 包括腺病毒相關病毒聚核苷酸的真核細胞 |
| US20250019668A1 (en) | 2021-10-29 | 2025-01-16 | Ultragenyx Pharmaceutical Inc. | Engineered cell lines for increased production of recombinant adeno-associated virus (raav) |
| WO2025078616A1 (en) * | 2023-10-12 | 2025-04-17 | Cevec Pharmaceuticals Gmbh | Cellular factors affecting recombinant aav production |
| WO2025226558A1 (en) | 2024-04-22 | 2025-10-30 | Ultragenyx Pharmaceutical Inc. | Multi-step filtration and clarification methods for recombinant adeno-associated virus purification |
| WO2026078664A1 (en) | 2024-10-10 | 2026-04-16 | Instituto De Biologia Experimental E Tecnológica (Ibet) | Transcription factor enhancing recombinant adeno-associated virus production, products, methods and uses thereof |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| US5387484A (en) | 1992-07-07 | 1995-02-07 | International Business Machines Corporation | Two-sided mask for patterning of materials with electromagnetic radiation |
| US5658785A (en) | 1994-06-06 | 1997-08-19 | Children's Hospital, Inc. | Adeno-associated virus materials and methods |
| CA2207927A1 (en) | 1994-12-06 | 1996-06-13 | Targeted Genetics Corporation | Packaging cell lines for generation of high titers of recombinant aav vectors |
| US5688676A (en) | 1995-06-07 | 1997-11-18 | Research Foundation Of State University Of New York | In vitro packaging of adeno-associated virus DNA |
| US5741683A (en) | 1995-06-07 | 1998-04-21 | The Research Foundation Of State University Of New York | In vitro packaging of adeno-associated virus DNA |
| JP2001506133A (ja) | 1996-12-18 | 2001-05-15 | ターゲティッド ジェネティクス コーポレイション | 組換えａａｖベクターの産生における使用のための、ａａｖスプリット−パッケージング遺伝子およびこのような遺伝子を含む細胞株 |
| US6156303A (en) | 1997-06-11 | 2000-12-05 | University Of Washington | Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom |
| DK1009808T3 (da) * | 1997-09-05 | 2013-01-21 | Genzyme Corp | Fremgangsmåder til generering af hjælper-frie præparater af rekombinante aav-vektorer med høj titer |
| EP1124976A1 (en) | 1998-10-27 | 2001-08-22 | Crucell Holland B.V. | Improved aav vector production |
| DE19905501B4 (de) | 1999-02-10 | 2005-05-19 | MediGene AG, Gesellschaft für molekularbiologische Kardiologie und Onkologie | Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels |
| US7510872B2 (en) | 2003-02-26 | 2009-03-31 | Nationwide Children's Hospital | Recombinant adeno-associated virus production |
| ATE530667T1 (de) | 2005-05-27 | 2011-11-15 | Evotec Neurosciences Gmbh | Kcnn3 als diagnostisches und therapeutisches target für alzheimer-krankheit |
| EP2311966A3 (en) | 2005-10-20 | 2012-09-05 | Amsterdam Molecular Therapeutics (AMT) B.V. | Improved AAV vectors produced in insect cells |
| US8188060B2 (en) | 2008-02-11 | 2012-05-29 | Dharmacon, Inc. | Duplex oligonucleotides with enhanced functionality in gene regulation |
| BR112015018493A2 (pt) | 2013-02-05 | 2017-08-22 | Univ Georgia | Linhagens celulares para produção de vírus e métodos de uso |
| CN104592364B (zh) * | 2013-10-30 | 2018-05-01 | 北京大学 | 定点突变和定点修饰的腺相关病毒、其制备方法及应用 |
| GB201401707D0 (en) * | 2014-01-31 | 2014-03-19 | Sec Dep For Health The | Adeno-associated viral vectors |
| US20160319277A1 (en) | 2015-01-28 | 2016-11-03 | The Johns Hopkins University | METHODS OF IMPROVED PROTEIN PRODUCTION USING MIRNAs AND SIRNAs |
| FI3436593T3 (fi) | 2016-03-28 | 2023-03-16 | Ultragenyx Pharmaceutical Inc | Adenoviruksen lämpöinaktivointimenetelmiä |
| WO2018013705A1 (en) | 2016-07-12 | 2018-01-18 | Dimension Therapeutics | Use of glucocorticoid analogs to enhance recombinant adeno-associated virus yield |
| PL3526321T3 (pl) | 2016-10-14 | 2025-04-28 | Ultragenyx Pharmaceutical Inc. | Zastosowanie środków regulujących ciśnienie osmotyczne w celu zwiększenia wydajności rekombinacyjnego wirusa związanego z adenowirusami |
| US20200048641A1 (en) | 2017-03-22 | 2020-02-13 | Ultragenyx Pharmaceutical Inc. | Methods for enhancing yield of recombinant adeno-associated virus |
| WO2018175775A1 (en) | 2017-03-22 | 2018-09-27 | Dimension Therapeutics | Cell culture methods involving hdac inhibitors or rep proteins |
| WO2018208960A1 (en) | 2017-05-09 | 2018-11-15 | Dimension Therapeutics, Inc. | Scalable method for producing transfection reagents |
| EP3740572A4 (en) | 2018-01-19 | 2022-01-05 | The University of North Carolina at Chapel Hill | PROCEDURES AND COMPOSITIONS FOR INHIBITION OF THE INHIBITAL IMMUNE-REACTION RELATED TO AAV TRANSDUCTION |
| WO2020219543A1 (en) | 2019-04-26 | 2020-10-29 | The Regents Of The University Of California | Cells for enhanced production of adeno-associated virus |
| US20250019668A1 (en) * | 2021-10-29 | 2025-01-16 | Ultragenyx Pharmaceutical Inc. | Engineered cell lines for increased production of recombinant adeno-associated virus (raav) |
-
2020
- 2020-04-09 SG SG11202110904PA patent/SG11202110904PA/en unknown
- 2020-04-09 US US16/844,475 patent/US12018288B2/en active Active
- 2020-04-09 CN CN202080028310.8A patent/CN113966395B/zh active Active
- 2020-04-09 EP EP25183274.7A patent/EP4603579A3/en active Pending
- 2020-04-09 CA CA3136246A patent/CA3136246A1/en active Pending
- 2020-04-09 WO PCT/US2020/027489 patent/WO2020210507A1/en not_active Ceased
- 2020-04-09 EP EP20722185.4A patent/EP3953458A1/en active Pending
- 2020-04-09 AU AU2020270960A patent/AU2020270960B2/en active Active
- 2020-04-09 JP JP2021559793A patent/JP7560475B2/ja active Active
- 2020-04-09 MX MX2021012489A patent/MX2021012489A/es unknown
- 2020-04-09 KR KR1020217036581A patent/KR20210152514A/ko active Pending
- 2020-04-09 PH PH1/2021/552577A patent/PH12021552577A1/en unknown
- 2020-04-09 BR BR112021020391A patent/BR112021020391A2/pt unknown
- 2020-04-10 TW TW109112259A patent/TWI859216B/zh active
-
2021
- 2021-10-07 IL IL287106A patent/IL287106A/en unknown
- 2021-10-14 CO CONC2021/0013699A patent/CO2021013699A2/es unknown
-
2024
- 2024-05-09 US US18/659,358 patent/US20240376440A1/en active Pending
- 2024-06-11 JP JP2024094278A patent/JP7706607B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022526646A5 (https=) | ||
| AU2019216665B2 (en) | RNA-guided human genome engineering | |
| CN109689677B (zh) | 用于基因组编辑分子的细胞内递送的肽和纳米颗粒 | |
| Papolu et al. | Retrotransposons: How the continuous evolutionary front shapes plant genomes for response to heat stress | |
| JP2024107295A5 (https=) | ||
| JP2018530336A5 (https=) | ||
| JP2016521993A5 (https=) | ||
| JP2022521787A5 (https=) | ||
| Zhang et al. | Amplification editing enables efficient and precise duplication of DNA from short sequence to megabase and chromosomal scale | |
| US20190211317A1 (en) | Peptides and nanoparticles for intracellular delivery of genome-editing molecules | |
| JP2022526646A (ja) | 操作された産生細胞株ならびにそれを作製および使用する方法 | |
| Uniyal et al. | The CRISPR–Cas9, genome editing approach: a promising tool for drafting defense strategy against begomoviruses including cotton leaf curl viruses | |
| Lieberman-Lazarovich et al. | Epigenetic alterations at genomic loci modified by gene targeting in Arabidopsis thaliana | |
| RU2021132765A (ru) | Линии сконструированных клеток-продуцентов и способы их получения и применения | |
| TH2101006399A (th) | เซลล์ไลน์ผู้ผลิตที่ผ่านการทำวิศวกรรม และวิธีการสร้างและการใช้สิ่งเดียวกันนี้ | |
| US20250257340A1 (en) | Guide nucleic acid identification and methods of use | |
| US20250308637A1 (en) | Systems and methods for assessing risk of genome editing events | |
| US20250354177A1 (en) | System and methods for duplicating target fragments | |
| HK40064529A (en) | Peptides and nanoparticles for intracellular delivery of genome-editing molecules | |
| WO2025199160A1 (en) | Systems and methods for delivery of crispr-cas gene editing machinery | |
| HK40103974A (en) | Rna-guided human genome engineering | |
| Garazha et al. | Structural and Functional Coevolution of Human Endogenous Retroviruses with Our Genome | |
| WO2018223843A1 (zh) | 用于dna编辑的系统及其应用 | |
| HK40014881A (en) | Rna-guided human genome engineering | |
| HK40006957B (en) | Peptides and nanoparticles for intracellular delivery of genome-editing molecules |